Kyverna Therapeutics, Inc. (KYTX)
NMS – Real vaqt narxi. Valyuta: USD
10.23
-0.11 (-1.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
10.27
+0.04 (0.39%)
Bozor oldidan: May 13, 2026, 4:27 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
10.23
-0.11 (-1.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
10.27
+0.04 (0.39%)
Bozor oldidan: May 13, 2026, 4:27 AM EDT
Kyverna Therapeutics, Inc., keyingi bosqichdagi biofarmatsevtika kompaniyasi, autoimmün kasalliklarga chalingan bemorlar uchun hujayra terapiyasini ishlab chiqishga qaratilgan. Uning yetakchi mahsulot nomzodi KYV-101 bo'lib, qattiq tana sindromi, miyasteniya gravis va autoimmün kasalliklarni davolash uchun CD19 ga qarshi yo'naltirilgan autolog CAR T-hujayrali mahsulot nomzodidir. Kompaniya shuningdek, to'liq qondan tez ishlab chiqariladigan autolog CD19 CAR T-hujayrali mahsulot nomzodi KYV-102 va allogen CD19 CAR T-hujayrali mahsulot nomzodi KYV-201ni ishlab chiqmoqda. U Intellia Therapeutics, Inc. bilan allogen CD19 ga qarshi yo'naltirilgan CAR hujayrali terapiyasi mahsulotini tadqiq qilish va ishlab chiqish bo'yicha litsenziya va hamkorlik shartnomasiga ega. Kompaniya ilgari BAIT Therapeutics, Inc. nomi bilan tanilgan va 2019-yil oktabr oyida Kyverna Therapeutics, Inc. nomini olgan. Kyverna Therapeutics, Inc. 2018-yilda ro'yxatga olingan va uning shtab-kvartirasi Kaliforniyaning Emervil shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Marc Grasso M.D. | Chief Financial Officer |
| Dr. Naji H. Gehchan M.B.A., M.D. | Chief Medical & Development Officer |
| Dr. Tom Van Blarcom Ph.D. | Senior VP & Head of Research |
| Mr. Dan Maziasz | Chief Business Officer |
| Mr. Mayo Pujols | Chief Technology Officer |
| Mr. Warner Biddle | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-04 | 8-K | kytx-20260415.htm |
| 2026-04-22 | 8-K | kytx-20260421.htm |
| 2026-04-20 | 8-K | kytx-20260420.htm |
| 2026-04-13 | DEFA14A | kytx_-_defa14a_proxy_not.htm |
| 2026-04-13 | DEF 14A | kytx-20260410.htm |
| 2026-03-31 | CORRESP | filename1.htm |
| 2026-03-26 | 10-K | kytx-20251231.htm |
| 2026-02-24 | 8-K | kytx-20260224.htm |
| 2026-02-03 | 8-K | kytx-20260129.htm |
| 2026-01-12 | 8-K | kytx-20260108.htm |
| Ms. Cara Bauer Ph.D. | Chief Human Resources Officer |
| Ms. Christi L. Shaw | Executive Chairperson |
| Ms. Jessica Serra | Head of Investor Relations |
| Ms. Tracy Rossin | Senior Vice President of Corporate Affairs & Communications and Investor Relations |